ATE357256T1 - Arzneimittel zur behandlung von störungen des zirkadianen rhythmus - Google Patents
Arzneimittel zur behandlung von störungen des zirkadianen rhythmusInfo
- Publication number
- ATE357256T1 ATE357256T1 AT03734884T AT03734884T ATE357256T1 AT E357256 T1 ATE357256 T1 AT E357256T1 AT 03734884 T AT03734884 T AT 03734884T AT 03734884 T AT03734884 T AT 03734884T AT E357256 T1 ATE357256 T1 AT E357256T1
- Authority
- AT
- Austria
- Prior art keywords
- circadian rhythm
- rhythm disorders
- bmal1
- jnk3
- agent
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- Neurology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Cell Biology (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002022857 | 2002-01-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE357256T1 true ATE357256T1 (de) | 2007-04-15 |
Family
ID=27654433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03734884T ATE357256T1 (de) | 2002-01-31 | 2003-01-30 | Arzneimittel zur behandlung von störungen des zirkadianen rhythmus |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20050037449A1 (de) |
| EP (1) | EP1479396B1 (de) |
| JP (1) | JPWO2003063907A1 (de) |
| AT (1) | ATE357256T1 (de) |
| CA (1) | CA2474689A1 (de) |
| DE (1) | DE60312656T2 (de) |
| WO (1) | WO2003063907A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2900936B1 (fr) * | 2006-05-15 | 2013-01-04 | Exonhit Therapeutics Sa | Procede et methodes de detection de la maladie d'alzheimer |
| RU2016110879A (ru) * | 2013-08-27 | 2017-10-03 | Сантори Холдингз Лимитед | Регулятор уровня экспрессии часовых генов |
| US11583226B2 (en) * | 2020-01-05 | 2023-02-21 | Kelly Huang | Method and system of monitoring and alerting patient with sleep disorder |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5877309A (en) * | 1997-08-13 | 1999-03-02 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotides against JNK |
| US6943000B2 (en) * | 1997-10-03 | 2005-09-13 | University Of Massachusetts | JNK3 modulators and methods of use |
| WO2000031132A1 (fr) * | 1998-11-24 | 2000-06-02 | Kyowa Hakko Kogyo Co., Ltd. | Nouveau polypeptide |
| DE60135676D1 (de) * | 2000-12-05 | 2008-10-16 | Vertex Pharma | Inhibitoren von c-jun n-terminalen kinasen (jnk) und anderen proteinkinasen |
-
2003
- 2003-01-30 DE DE60312656T patent/DE60312656T2/de not_active Expired - Fee Related
- 2003-01-30 CA CA002474689A patent/CA2474689A1/en not_active Abandoned
- 2003-01-30 WO PCT/JP2003/000881 patent/WO2003063907A1/ja active IP Right Grant
- 2003-01-30 JP JP2003563596A patent/JPWO2003063907A1/ja active Pending
- 2003-01-30 AT AT03734884T patent/ATE357256T1/de not_active IP Right Cessation
- 2003-01-30 EP EP03734884A patent/EP1479396B1/de not_active Expired - Lifetime
-
2004
- 2004-07-29 US US10/901,923 patent/US20050037449A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2474689A1 (en) | 2003-08-07 |
| US20050037449A1 (en) | 2005-02-17 |
| DE60312656T2 (de) | 2007-11-29 |
| EP1479396A4 (de) | 2005-08-03 |
| JPWO2003063907A1 (ja) | 2005-05-26 |
| DE60312656D1 (de) | 2007-05-03 |
| EP1479396B1 (de) | 2007-03-21 |
| WO2003063907A1 (fr) | 2003-08-07 |
| EP1479396A1 (de) | 2004-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE443043T1 (de) | Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer | |
| DE60330485D1 (de) | Zur behandlung von diabetes | |
| ATE157005T1 (de) | Verwendung von sertindol zur behandlung von schizophrenie | |
| ATE388951T1 (de) | Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes | |
| BR0211119A (pt) | Composto, método de tratar um paciente que tenha, ou de prevenir um paciente de pegar, uma doença ou condição, uso de um composto, e, método para fabricar um composto | |
| DE60310991D1 (de) | Phenylalaninderivate als hemmer der dipeptidyl peptidase zur behandlung oder prävention von diabetes | |
| ATE368031T1 (de) | Neue gamma secretase inhibitoren | |
| DE60311820D1 (de) | Neue verwendung von pyrimidin- oder triazin-2-carbonsäurenitrilen zur behandlung von krankheiten, die mit cysteinproteaseaktivität assoziiert sind, und neue pyridimidin-2-carbonsäurenitrilderivate | |
| NO2008013I1 (no) | Sitagliptin, eventuelt i form av et farmasoytisk akseptabelt salt, saerling monofosfatet, pluss metformin, eventuelt i form av et farmasoytisk akseptabelt salt, saerling hydrokloridet | |
| DE60329533D1 (de) | Cyclische sulfamide zur inhibierung von gamma-sekretase | |
| DE69521424T2 (de) | Benzofuran derivate und ihre verwendung als inhibitoren der knochenresorption | |
| ATE447574T1 (de) | 3-amino-4-phenylbutansäurederivate als dipeptidylpeptidase-hemmer zur behandlung oder vorbeugung von diabetes | |
| DE60226729D1 (de) | Hydroxyalkylaminderivate als beta-secretase-inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten | |
| DE602004011255D1 (de) | Phosphinsäurederivate, inhibitoren von beta-sekretase zur behandlung von alzheimer-krankheit | |
| ATE357438T1 (de) | 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems | |
| ATE439833T1 (de) | Pharmazeutische zubereitung enthaltend ein catechin, ascorbinsäure, prolin und lysin zur behandlung von neoplastischen krankheiten | |
| DE60221283D1 (de) | Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden | |
| CY1105545T1 (el) | Θεραπεια στατινης για ενισχυση της διατηρησης νοητικης λειτουργιας | |
| ATE326964T1 (de) | Aminosäurederivate zur behandlung der alzheimer- krankheit | |
| ATE357256T1 (de) | Arzneimittel zur behandlung von störungen des zirkadianen rhythmus | |
| DE602005007471D1 (de) | Satraplatin zur behandlung von resistenten oder refrkatären tumoren | |
| ATE432936T1 (de) | Imidazotriazin verbindungen zur behandlung von krebserkrankungen | |
| BR0314180A (pt) | Aminoéteres substituìdos para o tratamento da doença de alzheimer | |
| DE69230790T2 (de) | Arzneimittel zur Behandlung von durch Babesia verursachten Protozoeninfektionen | |
| ATE421961T1 (de) | Piperidinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzung zur behandlung von alzheimer-krankheit, die diese derivate enthält |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |